Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TMX 049

Next Previous
Drug Profile

TMX 049

Alternative Names: TMX 049DN; TMX-049

Latest Information Update: 11 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Teijin Pharma
  • Class Antigouts; Uricosurics
  • Mechanism of Action Xanthine oxidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Diabetic nephropathies; Gout; Hyperuricaemia

Most Recent Events

  • 07 Apr 2022 XORTX Pharma receives notification of intent to grant from the United States Patent Office for a patent covering xanthine oxidase inhibitors
  • 06 Apr 2021 XORTX Pharma has patent protection for the use of uric acid lowering agents to treat chronic progressing kidney disease, hypertension, insulin resistance, and diabetic nephropathy, in USA and Europe Union
  • 06 Apr 2021 XORTX Pharma receives notification of intent to grant a patent covering the use of uric acid lowering agents to treat and prevent diabetic nephropathies, in European Union

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top